 Richard C. Mulligan, Ph.D., (born 1954) is the Mallinckrodt Professor of Genetics at Harvard Medical School, and Director of the Harvard Gene Therapy Initiative. He is a Director of Enzon Pharmaceuticals, Inc., and Biogen Idec, Inc.. {{Persondata | NAME = Mulligan, Richard C. | ALTERNATIVE NAMES =| SHORT DESCRIPTION =| DATE OF BIRTH = 1954 | PLACE OF BIRTH =| DATE OF DEATH =| PLACE OF DEATH =}} 
